Prescribing errors in diabetes

British Journal of Diabetes and Vascular Disease

Volumn 9, Issue 2, 2009, Pages 84-88

  Cox, Anthony R ^a,b   Ferner, Robin E ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Adverse events; Hyperglycaemia; Hypoglycaemia; Insulin; Prescribing error; Sulphonylurea

Indexed keywords

ANTIDIABETIC AGENT; CHLORPROPAMIDE; DIGOXIN; GLIBENCLAMIDE; GLIPIZIDE; HUMAN INSULIN; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; SULFONYLUREA; WARFARIN;

ADVERSE DRUG REACTION; COMMUNICATION SKILL; CONSCIOUSNESS; DIABETES MELLITUS; DRUG CHOICE; DRUG NOMENCLATURE; DRUG SAFETY; EXPERIENCE; HANDWRITING; HUMAN; HYPOGLYCEMIA; MEDICAL EDUCATION; MEDICATION ERROR; NOMENCLATURE; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; SIDE EFFECT; UNITED KINGDOM;

EID: 73349111263     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651409103902     Document Type: Review

References (53)

1. Kohn LT, Corrigan JM, Donaldson MS (eds.). To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press, 1999.
2. Department of Health. An Organisation With A Memory. London: Department of Health, 2000.
3. Ferner RE, McDowell SE Doctors charged with manslaughter in the course of medical practice, 1795-2005: a literature review. J R Soc Med 2006: 99: 306-314.
4. Lewis PJ, Dornan T., Taylor D. et al. The prevalence and incidence of prescribing errors: systematic review: Report to The General Medical Council. December 2008. The Academy for the Study and Development of the Pharmacy Workforce. Manchester: Manchester University, 2008.
5. Ferner RE, Aronson JK Clarification of terminology in Medication Errors. Drug Saf 2006 ; 26 (11). 1011-1022
6. Reason J. Human Error. Cambridge: Cambridge University Press, 1990.
7. van der Hooft CS, Sturkenboom Mcjm, van Grootheest K. et al. Adverse drug reaction-related hospitalisations. Drug Saf 2006 ; 26 (2). 161-168.
8. Varghese P., Gleason V., Sorokin R. et al. Hypoglycaemia in hospitalised patients treated with antihyperglycaemic agents. J Hosp Med 2007 ; 2: 234-240.
9. Stepka M. Rogla H., Czyzyk A. Hypoglycaemia: A major problem in the management of diabetes in the elderly. Aging Clin Exp Res 1993 ; 5: 117-121.
10. Leese GP, Wang J., Broomhall J. et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003 ; 26: 1176-1180.
11. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003 ; 289: 1107-1116.
12. Lesar LS Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. Arch Interm Med 1997 ; 157: 1569-1576.
13. Lesar LS Prescribing errors involving medication dosage forms. J Gen Intern Med 2002 ; 17: 579-587.
14. Ferner RE, Neil HAW. Sulphonylurea and hypoglycaemia. BMJ 1998 ; 296: 949-950.
15. Girardin E., Vial T., Pham E., Evreux JC Hypoglycémies induites par les sulfamides hypoglycémiants: Recensement par les Centres Régionaux de Pharmacovigilance fran?§ais de 1985 1990. Ann Med Interne 1992 ; 143 (1). 11-17.
16. Schlozman SC, Hennessey JV Mechanical misadministration of an oral hypoglycaemic agent. Diabetes Care 1997 ; 20 (11). 1796-1797.
17. Ludman P., Mason P., Joplin GF Dangerous misuse of sulphonylureas. BMJ 1986 ; 293: 1287-1288.
18. Mayer GA Chlorpropamide or chlorpromazine? Can Med Assoc J 1991 ; 144: 119.
19. Singh R. How a series of errors led to recurrent hypoglycaemia. J Fam Pract 2006 ; 55: 489-497.
20. Ferner RE, Neil HAW. Sulphonylureas and hypoglycaemia. BMJ 1988 ; 296: 949-950.
21. Amiel SA, Dixon T., Mann R., K. Jameson. Hypoglycaemia in Type 2 diabetes. Diabet Med 2008 ; 25: 245-254.
22. Shorr RI, Ray WA, Duaghty JR, Griffin MR Individual sulfonylureas and serious hypoglycaemia in older people. J Am Geriatr Soc 1996 ; 44: 751-755.
23. Budnitz DS, Shehab N., Kegler SR, Richards CL Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007 ; 147: 755-765.
24. Santell JP, Hicks RW, Cousins DD Medication errors in emergency department settings: 5 year review. Rockville: The United States Pharmacopeia, June 2004. http://www.usp.org/hqi/patientSafety/resources/posters/ posterEmergencyDept.html. (Accessed 11 February 2009).
25. U.S. Pharmacopeia. Insulin errors: a common problem. USP Patient Safety CAPSLink. July 2003. Section 1: USP Medication Error Analysis. Rockville: The United States Pharmacopeia, 2003. http://www.usp.org/pdf/EN/patientSafety/ capsLink2003-07-01.pdf. (Accessed 12 February 2009 ).
26. Santell JP, Cousins DD, Hicks R. Top 10 drugs products involved in medication errors. Drug Topics 2003 ; 147 (23). HSE23-4.
27. Cohen MR, Smetzer JL, Touhy NR, Kilo CM High-Alert medications: Safeguarding against errors. In: Cohen MR (ed.). Medication Errors. 2 nd edition Washington, DC: American Pharmaceutical Association, 2007 ; 317-412.
28. Lesar LS Prescribing errors involving medication dosage forms. J Gen Intern Med 2002 ; 17: 579-587.
29. Institute for Safe Medication Practices. Proliferation of insulin combination products increases opportunity for errors. Medication Safety Alert! 27 November 2002. Horsham: Institute for Safe Medication Practices, 2002. http://www.ismp.org/Newsletters/acutecare/articles/20021127.asp?ptr=y. (Accessed 11 February 2009 ).
30. Fallon JJ, Stefenelli G., Grant H., Voytovich RM Insulin-related hospital incidents. Diabetes Care 1986 ; 9: 98-99.
31. Ponte CD Monitoring the patient with diabetes mellitus: how to avoid medication errors. Hosp Pharm 1989 ; 24: 280-289.
32. Institute for Safe Medication Practices. ISMP's List of Error-Probe Abbreviations, Symbols, and Dose Designations. Horsham: Institute for Safe Medication Practices, 2007. www.ismp.org/Tools/errorproneabbreviations.pdf. (Accessed 11 February 2009 ).
33. Paparella SP Avoiding errors with insulin therapy. J Emerg Nurs 2006: 42: 325-328.
34. Miles M., Sweeney S. Insulin dose interpretation errors. The Pharmaceutical Journal 2001 ; 267: 191-193.
35. Adlersberg MA, Fernado S., Spollett GR, Inzucchi SE Glargine and Lispro. Diabetes Care 2002 ; 25: 404-405.
36. Phillips W., Lando H. Insulin confusion: an observation. Diabetes Care 2002 ; 25: 1103
37. Bates DW, Cullen DJ, Laird N. et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995 ; 274: 29-34.
38. Hellman R. Patients safety and inpatient glycaemic control: translating concepts into action. Endocr Pract 2006: 12 (3). 49-55.
39. Gill G., MacFarlane I. Are sliding-scale insulin regimens a recipe for diabetic instability? Lancet 1997 ; 349: 1555.
40. Rozich JD, Howard RJ, Justeson JM et al. Standardisation as a mechanism to improve safety in Healthcare. Joint Comm J Qual Saf 2004 ; 30 (1). 5-14.
41. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT Use of a standardised protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care 2006 ; 15: 89-91.
42. Ridge RA Boosting insulin safety. Nursing 2007 ; 37 (2). 14-15.
43. Derr RL, Sivanandy MS, Bronich-Hall L., Rodriguez A. Insulin-related knowledge among health care professional in internal medicine. Diabetes Spectrum 2007 ; 20: 177-185.
44. Page MD, Stephenson C., Pope RM, Bodansky HJ Prescribing and dispensing of insulin: margins for error? Diabet Med 1992 ; 9: 938-941.
45. Institute for Safe Medication Practices. ISMP quarterly action agenda: July and September 2007. ISMP Medication Safety Alert! 4 October 2007. Horsham: Institute for Safe Medication Practices, 2007. http://www.ismp.org/Newsletters/ acutecare/articles/A4Q07Action.asp. (Accessed 11 July 2009 ).
46. Institute for Safe Medication Practices. ISMP Medication Safety Alert! Community/Ambulatory Care Edition 2007 ; 6 (9). 1.
47. Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract 2004 ; 10 (2). 100-108.
48. Clarke NR, Narendran P. Insulin prescribing is unsafe: education results in a significant but insufficient improvement. Diabet Med 2005 ; 22: 1779-1780.
49. Langford NJ, Martin U., Kendall MJ, Ferner RE Medical errors. Medical schools can teach safe drug prescribing and administration. BMJ 2001 ; 322: 1424.
50. Maxwell S., Walley T. Teaching safe and effective prescribing in UK medcial schools: a core curriculum for tomorrow's doctors. B J Clin Pharm 2003 ; 55: 496-503.
51. The ACE/ADA Task Force on Inpatient Diabetes. The American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycaemic Control: A call to action. Diabetes Care 2006 ; 29: 1955-1962.
52. Feher MD, Bailey CJ Reclassifying insulins. Br J Diabetes Vasc Dis 2004 ; 4: 39-42
53. National Patient Safety Agency. Technical patient safety solutions for medicines reconciliation on admission of adults to hospital. December 2007. Alert Reference: NICE/NPSA/2007/PSG001. London: National Patient Safety Agency, 2007.